Literature DB >> 18688121

The European Organization for Research and Treatment of Cancer prostate-specific quality of life module (PR-25) in Hindi and Marathi: translation and pilot testing process.

Tabassum Wadasadawala1, Vedang Murthy, Umesh Mahantshetty, Reena Engineer, Shyamkishore Shrivastava, Ketayun Dinshaw.   

Abstract

BACKGROUND: The side effects of various treatments for prostate cancer have a measurable impact on the general as well as disease-related quality of life, which is of pivotal concern as an outcome measure. AIM: Translation and pilot testing of the European Organization for Research and Treatment of Cancer (EORTC) prostate cancer-specific module (PR-25) into Hindi and Marathi.
MATERIALS AND METHODS: The translation procedure described by the EORTC was adopted; this comprised two forward translations of the original English questionnaire into Hindi and Marathi each with formation of first intermediary questionnaires and two back translations of the first intermediary questionnaires into English. The first intermediary questionnaires were adapted as the second intermediary questionnaires and pilot tested in ten prostate cancer patients as no modifications were suggested by the back translators.
RESULTS: Each patient, after completing the questionnaire, was interviewed by the local project coordinator who questioned them about each item in the second intermediary questionnaire. The patients were asked whether there was any difficulty in answering, confusion while answering, or difficulty in understanding the questions; whether the questions were upsetting; and if the patients themselves would have framed the question in a different way. Based on the suggestions or interpretations of this pilot testing, the necessary changes were incorporated and the final Hindi and Marathi questionnaires were formed.
CONCLUSION: Both the translations were submitted to the EORTC for review and have been subsequently approved for clinical studies.

Entities:  

Mesh:

Year:  2008        PMID: 18688121     DOI: 10.4103/0973-1482.42251

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  2 in total

1.  Maximal androgen blockade for advanced prostate cancer.

Authors:  Rajiv Paul Mukha; Santosh Kumar; N S Kekre
Journal:  Indian J Urol       Date:  2010 Jan-Mar

2.  Pilot Testing and Preliminary Psychometric Validation of the Polish Translation of the EORTC INFO25 Questionnaire: Validation of the Polish version of INFO25-pilot study.

Authors:  Mirosława Püsküllüoğlu; Krzysztof A Tomaszewski; Aneta L Zygulska; Sebastian Ochenduszko; Joanna Streb; Iwona M Tomaszewska; Krzysztof Krzemieniecki
Journal:  Appl Res Qual Life       Date:  2013-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.